BriaCell Therapeutics Corp. (BCTX)

NASDAQ: BCTX · Real-Time Price · USD

4.280

-0.260 (-5.73%)

At close: Apr 10, 2026, 4:00 PM EDT

4.450

+0.170 (3.97%)

After-hours: Apr 10, 2026, 7:34 PM EDT

BriaCell Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 10, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Market Cap	31	14	14	101	92	71
Market Cap Growth	106.23%	1.06%	-86.55%	9.34%	30.61%	1321.88%
Enterprise Value	0.7	0.45	12.44	80.87	54.49	19.2
PE Ratio	-	-0.12	-2.56	-5.11	-3.78	-1.68
PB Ratio	1.02	1.06	-5.72	-28.09	9.67	2.84
P/TBV Ratio	0.28	0.33	-7.11	-36.22	12.58	1.05
P/FCF Ratio	-	-0.49	-0.55	-4.47	-8.00	-10.14
P/OCF Ratio	-	-0.49	-0.57	-4.47	-8.00	-10.14
EV/EBITDA Ratio	-	-0.02	-0.38	-3.65	-3.85	-3.06
EV/EBIT Ratio	-	-0.02	-0.37	-3.65	-3.85	-3.05
EV/FCF Ratio	-	-0.02	-0.51	-3.57	-4.71	-2.75
Net Debt / Equity Ratio	-0.97	-1.00	0.36	5.63	-3.97	-2.07
Net Debt / EBITDA Ratio	0.78	0.48	0.03	0.91	2.69	8.23
Net Debt / FCF Ratio	0.82	0.46	0.04	0.90	3.29	7.39
Quick Ratio	10.10	5.01	0.49	14.96	43.64	102.88
Current Ratio	10.10	5.01	0.49	14.96	45.00	103.81
Return on Equity (ROE)	-191.31%	-540.66%	152.63%	-619.75%	-141.25%	-114.78%
Return on Assets (ROA)	-166.87%	-253.13%	-201.78%	-66.74%	-30.39%	-23.82%
Return on Invested Capital (ROIC)	-77732.50%	2099.63%	-4015.57%	-989.19%	-3763.04%	465.90%
Return on Capital Employed (ROCE)	-193.67%	-487.40%	-280.40%	-69.47%	-30.85%	-25.82%
Earnings Yield	-96.45%	-853.09%	-39.04%	-19.58%	-26.44%	-59.47%
FCF Yield	-100.78%	-205.12%	-180.25%	-22.38%	-12.50%	-9.86%
Buyback Yield / Dilution	-784.70%	-285.70%	-5.35%	-0.81%	-242.82%	-533.09%
Total Shareholder Return	-784.70%	-285.70%	-5.35%	-0.81%	-242.82%	-533.09%

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q